Cargando…

Macrophage in chronic kidney disease

Chronic kidney disease (CKD) has become a major health problem worldwide. This review describes the role of macrophages in CKD and highlights the importance of anti-inflammatory M2 macrophage activation in both renal fibrosis and wound healing processes. Furthermore, the mechanisms by which M2 macro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guiteras, Roser, Flaquer, Maria, Cruzado, Josep M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Translational Nephrology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5162417/ https://www.ncbi.nlm.nih.gov/pubmed/27994852 http://dx.doi.org/10.1093/ckj/sfw096

Ejemplares similares

Exploring macrophage cell therapy on Diabetic Kidney Disease
por: Guiteras, Roser, et al.
Publicado: (2018)

Omics databases on kidney disease: where they can be found and how to benefit from them
por: Papadopoulos, Theofilos, et al.
Publicado: (2016)

Effect of telmisartan on kidney function in patients with chronic kidney disease: an observational study
por: Agrawal, Ashish, et al.
Publicado: (2016)

Frailty in Patients With Chronic Kidney Disease Stage Five
por: Joseph, Jerry, et al.
Publicado: (2023)

Rethink nutritional management in chronic kidney disease care
por: Chen, Fangyue, et al.
Publicado: (2023)

Retaining Race in Chronic Kidney Disease Diagnosis and Treatment
por: Williams, Paul
Publicado: (2023)

Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients
por: Shouqair, Tasneem M, et al.
Publicado: (2022)

Is Chronic Kidney Disease a Critical Health Problem in Madeira Island?
por: Vida, Ana Carlota, et al.
Publicado: (2023)

Management of Chronic Kidney Disease in Morocco: A Cost-of-Illness Study
por: Chrifi Alaoui, Amina, et al.
Publicado: (2023)

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors
por: Frías, Aida, et al.
Publicado: (2023)

Metabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid
por: Perales-Quintana, Marlene Marisol, et al.
Publicado: (2019)

Documenting Disease in the Undocumented Migrants: A Case Report of Chronic Kidney Disease of Unknown Origin in a Central American Migrant
por: Singh, Adityabikram, et al.
Publicado: (2022)

Is exposure to hydrocarbons associated with chronic kidney disease in young Nigerians? A case–control study
por: Okoye, Ogochukwu Chinedum, et al.
Publicado: (2022)

Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease
por: Hill, Claire, et al.
Publicado: (2022)

Chronic Kidney Disease Education Class Improves Rates of Early Access Creation and Peritoneal Dialysis Enrollment
por: Aloudah, Saud A, et al.
Publicado: (2022)

Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature
por: Teo, Wei Yi, et al.
Publicado: (2022)

Mechanisms underlying acupuncture therapy in chronic kidney disease: A narrative overview of preclinical studies and clinical trials
por: Liu, Xinyin, et al.
Publicado: (2022)

Effects of the Modified Antitubercular Treatment Regimen on Renal Function in Patients With Chronic Kidney Disease and Pulmonary Tuberculosis: An Observational Study
por: Tripathy, Aakankshya, et al.
Publicado: (2023)

The cell cycle biomarkers: promising research, but do not oversell them
por: Lameire, Norbert, et al.
Publicado: (2016)

Changes in Serum and Urinary Potassium Handling Associated with Renin-Angiotensin-Aldosterone System Inhibitors in Advanced Chronic Kidney Disease Patients
por: Ueda, Yuichiro, et al.
Publicado: (2019)

Social determinants and chronic kidney disease of undetermined origin in childhood: Its communication and understanding described by families in Lake Chapala, Mexico
por: Ruiz-Velazco, Norma Guadalupe, et al.
Publicado: (2022)

The Cardiovascular Literature-Based Risk Algorithm (CALIBRA): Predicting Cardiovascular Events in Patients With Non-Dialysis Dependent Chronic Kidney Disease
por: Neri, Luca, et al.
Publicado: (2022)

Reducing the Sodium Intake of Patients With Chronic Kidney Disease Through Education and Estimating Salt Excretion: A Propensity Score Matching Analysis
por: Shima, Hisato, et al.
Publicado: (2023)

Outcomes in older kidney recipients from older donors: A propensity score analysis
por: Cuadrado-Payán, Elena, et al.
Publicado: (2022)

Management of Uremic Xerosis and Chronic Kidney Disease (CKD)-Associated Pruritus (CKD-ap) With Topical Preparations: A Systematic Review and Implications in the Indian Context
por: Verma, Veena, et al.
Publicado: (2023)

Digital health technology to support care and improve outcomes of chronic kidney disease patients: as a case illustration, the Withings toolkit health sensing tools
por: Canaud, Bernard, et al.
Publicado: (2023)

Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study
por: Sinha, Shubhadeep D, et al.
Publicado: (2021)

Extracorporeal organ support and the kidney
por: Muciño-Bermejo, Maria-Jimena
Publicado: (2022)

Factors associated with poor self-rated health among chronic kidney disease patients and their health care utilization: Insights from LASI wave-1, 2017-18
por: Nayak, Swetalina, et al.
Publicado: (2023)

Plant-derived compounds for treating autosomal dominant polycystic kidney disease
por: Zhang, Jieting, et al.
Publicado: (2023)

Modulation of stroke risk in chronic kidney disease
por: Arnold, Julia, et al.
Publicado: (2016)

Biomarkers of iron metabolism in chronic kidney disease
por: Tomasz, Glogowski, et al.
Publicado: (2020)

The Effect of Statins on Mortality of Patients With Chronic Kidney Disease Based on Data of the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) and Korea National Health Insurance Claims Database
por: Kim, Ji Eun, et al.
Publicado: (2022)

Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension
por: Hanratty, Rebecca, et al.
Publicado: (2009)

Progression of kidney injury with the combination of vancomycin and piperacillin-tazobactam or cefepime in sepsis-associated acute kidney injury
por: Whitenack, Kaylee, et al.
Publicado: (2022)

Insulin and the kidneys: a contemporary view on the molecular basis
por: Daza-Arnedo, Rodrigo, et al.
Publicado: (2023)

The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
por: Tarabzuni, Ola
Publicado: (2022)

Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
por: Torigoe, Kenta, et al.
Publicado: (2022)

Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan
por: Gkekas, Eleftherios, et al.
Publicado: (2022)

Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients
por: Loutradis, Charalampos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_68b154prf1kh3eha7qejp6hi1u